Trinity Biotech | TRIB - Current Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Trinity Biotech

Trinity Biotech reported $46.67M in Current Assets for its fiscal quarter ending in December of 2022.


Current Assets Change
Abbott ABT:US USD 24.38B 847M
Bayer BAYN:GR EUR 39.62B 1.86B
Bio-Rad Laboratories BIO:US USD 3.28B 119.28M
EDAP TMS EDAP:US EUR 89.17M 1.35M
J&J JNJ:US USD 64.39B 9.09B
Mesa Laboratories MLAB:US USD 118.98M 4.79M
OraSure Technologies OSUR:US USD 343.6M 17.88M
Plus Therapeutics, Inc. CYTX:US USD 13.63M 8.19M
Roche Holding ROG:VX CHF 33.82B 3.5B
Siemens SIE:GR EUR 57.74B 855M
Sientra SIEN:US USD 96.93M 10.82M
Surmodics SRDX:US USD 61.24M 3.22M
Thermo Fisher Scientific TMO:US USD 20.21B 5.16B
Tosoh 4042:JP JPY 707.62B 12.27B
Trinity Biotech TRIB:US USD 46.67M 3.17M
Veracyte VCYT:US USD 251.5M 2.87M